PRONEX PHARMA LIMITED
Significant control: Dheyaa Jaafar Mohammed Samaka (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Pronex Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Pronex Pharma Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
PRONEX PHARMA LIMITED is an active private limited company (company number 13059073) incorporated on 3 December 2020, registered in London. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest dormant accounts cover the period ending 31 December 2025, showing net assets of £3 and cash of £3. Net assets were unchanged on the prior period.
By net assets it sits in the lower half of 435 comparable companies in London (median £2,000, upper quartile £90k).
Ownership and control
- Mr Dheyaa Jaafar Mohammed Samaka
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Haider Dheyaa Jaafar Samaka
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr. Ali Dheyaa Jaafar Samaka
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Dheyaa Jaafar Mohammed Samaka
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 3 December 20205 yrs ago
- Next accounts due
- 30 September 2027in 341 days
- Confirmation statement due
- 17 December 2026in 54 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £3 | £3 | — | — | — | — | — |
| 31 December 2024 | £3 | £3 | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £3 at 31 December 2025
- Incorporated five or more years agoIncorporated 3 December 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 341 days
- Confirmation statement duein 54 days
- Accounts period endNet assets £3 · dormant accounts
- Accounts period endNet assets £3 · dormant accounts
- Incorporated
Similar companies in London
- EWP&H UK LTDLondon · inc. Dec 2020
- HARROW PHARMA LTDLondon · inc. Dec 2020
- CYLOGENE UK LIMITEDLondon · inc. Nov 2020
- LIFECARE EUROPE LIMITEDLondon · inc. Nov 2020
- INBODY UK LIMITEDLondon · inc. Dec 2020
- WATERWIPES UK LIMITEDLondon · inc. Nov 2020
All companies incorporated on 3 December 2020 · in Dec 2020.
Reminders for PRONEX PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.